Airway blood flow reactivity in smokers

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 2, 2007, Pages 126-129

  Wanner, Adam ^a   Campos, Michael A ^a   Mendes, Eliana ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Airway blood flow; Albuterol; Cigarette smoke; Endothelial dysfunction

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; SALBUTAMOL;

ADULT; AIRWAY; ARTICLE; BLOOD FLOW; BRACHIAL ARTERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SMOKING;

ADMINISTRATION, INHALATION; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY CIRCULATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 33751189855     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2005.12.004     Document Type: Article

References (26)

1. Celermajer D.S., et al. Cigarette smoking is associated with dose-dependent and potentially reversible impairment of endothelium-dependent dilatation in healthy young adults. Circulation 88 (1993) 2146-2155
2. Butler R., et al. Cigarette smoking in men and vascular responsiveness. Br J Clin Pharmacol 52 (2001) 145-149
3. Wiesmann F., et al. Global impairment of brachial, carotid, and aortic vascular function in young smokers. J Am Coll Cardiol 44 (2004) 2056-2064
4. Zeiher A.M., et al. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 92 (1995) 1094-1100
5. Adams M.R., et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 32 (1998) 123-127
6. Neunteufl T., et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 39 (2002) 251-256
7. Campisi R., et al. Effects of long-term smoking on myocardial blood flow, coronary vasodilation, and vasodilator capacity. Circulation 98 (1998) 119-125
8. Budhiraja R., et al. Endothelial dysfunction in pulmonary hypertension. Circulation 109 (2004) 159-165
9. Peinado V.I., et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Lung Cell Mol Physiol 274 (1998) 908-913
10. Dinh-Xuan A.T., et al. Impairment of pulmonary-artery endothelium-dependent relaxation in COPD is not due to dysfunction of endothelial cell membrane receptors nor to l-arginine deficiency. Br J Pharmacol 109 (1993) 587-591
11. Wright J.L., et al. Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries. Am J Resp Cell Mol Biol 31 (2004) 501-509
12. Barbera J.A., et al. Reduced expression of endothelial nitric oxide-synthase in pulmonary arteries of smokers. Am J Resp Crit Care Med 164 (2001) 709-713
13. Hayward C.S., et al. Assessment of endothelial function using peripheral waveform analysis. J Am Coll Cardiol 40 (2002) 521-528
14. Lind, et al. Methodological aspects of the evaluation of endothelium-dependent vasodilation in the human forearm. Clin Physiol 18 (1998) 81-87
15. Covic A., et al. Hemodialysis acutely improves endothelium-independent vasomoteor function without significantly influencing the endothelium-mediated abnormal response to a beta2-agonist. Nephrol Dial Transpl 19 (2004) 637-643
16. Dawes M., et al. Quantitative aspects of the inhibition of N(G)-monomethyl-l-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature. Br J Pharmacol 134 (2001) 939-944
17. Dawes M., et al. Effects of inhibition of the l-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in the human forearm. Circulation 95 (1997) 2293-2297
18. Yao K., et al. Effects of beta-adrenoceptor stimulation on endothelial nitric oxide synthase phosphorylation of human umbilical vein endothelial cells. Acta Pharmacol Sin 24 (2003) 219-224
19. Schindler C., et al. Mechanisms of beta-adrenergic receptor-mediated vasodilation. Clin Pharmacol Ther 75 (2004) 49-59
20. Baile E.M., et al. Bronchial arterial response to contrast medium. Acad Radiol 2 (1995) 980-984
21. Carvalho P., et al. Non-cAMP-mediated bronchial arterial vasodilation in response to inhaled beta-agonists. J Appl Physiol 84 (1998) 215-221
22. Suh H.S., et al. Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in un-complicated pre-menopausal obese women. Int J Obesity 1 (2004) 1-6
23. Mendes ES, Campos MA, Wanner A. Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. Chest 2005, in press.
24. Onorato D.J., Demirozu M.C., Breitenbücher A., Atkins N.D., Chediak A.D., and Wanner A. Airway mucosal blood flow in man: response to adrenergic agonists. Am J Respir Crit Care Med 149 (1994) 1132-1137
25. Brieva J.L., Danta I., and Wanner A. Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma. Am J Respir Crit Care Med 161 (2000) 293-296
26. Scuri M., McCaskill V., Chediak A.D., Abraham W.M., and Wanner A. Measurement of airway mucosal blood flow with dimethylether: validation with microspheres. J Appl Physiol 79 (1995) 1386-1390